BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 32487905)

  • 1. Anticancer Drugs and the Nervous System.
    Santomasso BD
    Continuum (Minneap Minn); 2020 Jun; 26(3):732-764. PubMed ID: 32487905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticancer Drugs and the Nervous System].
    Fukutake T
    Brain Nerve; 2021 Jan; 73(1):21-33. PubMed ID: 33361511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system injury from novel cancer immunotherapies.
    Winter SF; Vaios EJ; Dietrich J
    Curr Opin Neurol; 2020 Dec; 33(6):723-735. PubMed ID: 32941192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurologic complications of cancer drug therapies.
    Lee EQ; Arrillaga-Romany IC; Wen PY
    Continuum (Minneap Minn); 2012 Apr; 18(2):355-65. PubMed ID: 22810132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurologic Complications of Cancer Therapies.
    Lee EQ
    Curr Neurol Neurosci Rep; 2021 Nov; 21(12):66. PubMed ID: 34817688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurologic side effects of cytotoxic drugs].
    Lebrun C; Frenay M
    Rev Med Interne; 2010 Apr; 31(4):295-304. PubMed ID: 20167398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials.
    Bruna J; Argyriou AA; Anastopoulou GG; Alemany M; Nadal E; Kalofonou F; Piulats JM; Simó M; Velasco R; Kalofonos HP
    J Peripher Nerv Syst; 2020 Jun; 25(2):171-177. PubMed ID: 32166812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic Complications of Cancer Immunotherapy.
    Wang N
    Continuum (Minneap Minn); 2023 Dec; 29(6):1827-1843. PubMed ID: 38085900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity of Cancer Therapies.
    Dietrich J
    Continuum (Minneap Minn); 2020 Dec; 26(6):1646-1672. PubMed ID: 33273176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic Toxicities of Cancer Immunotherapies: a Review.
    Harrison RA; Tummala S; de Groot J
    Curr Neurol Neurosci Rep; 2020 Jun; 20(7):27. PubMed ID: 32514633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in treatments of patients with classical and emergent neurological toxicities of anticancer agents.
    Bompaire F; Birzu C; Bihan K; Desestret V; Fargeot G; Farina A; Joubert B; Leclercq D; Nichelli L; Picca A; Tafani C; Weiss N; Psimaras D; Ricard D
    Rev Neurol (Paris); 2023 Jun; 179(5):405-416. PubMed ID: 37059646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-treatment-induced neurotoxicity--focus on newer treatments.
    Stone JB; DeAngelis LM
    Nat Rev Clin Oncol; 2016 Feb; 13(2):92-105. PubMed ID: 26391778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotoxicity associated with cancer immunotherapy: immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy.
    Perrinjaquet C; Desbaillets N; Hottinger AF
    Curr Opin Neurol; 2019 Jun; 32(3):500-510. PubMed ID: 30893101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological toxicities associated with immune-checkpoint inhibitors.
    Touat M; Talmasov D; Ricard D; Psimaras D
    Curr Opin Neurol; 2017 Dec; 30(6):659-668. PubMed ID: 28938341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurologic Complications of Systemic Anticancer Therapy.
    Ly KI; Arrillaga-Romany IC
    Neurol Clin; 2018 Aug; 36(3):627-651. PubMed ID: 30072074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.
    Reynolds KL; Guidon AC
    Oncologist; 2019 Apr; 24(4):435-443. PubMed ID: 30482825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Nervous System Complications of Oncologic Therapy.
    Hoeffner EG
    Hematol Oncol Clin North Am; 2016 Aug; 30(4):899-920. PubMed ID: 27444003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity?
    Cavaletti G; Alberti P; Marmiroli P
    Am Soc Clin Oncol Educ Book; 2015; ():e553-60. PubMed ID: 25993222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic complications of cancer chemotherapy.
    Sul JK; Deangelis LM
    Semin Oncol; 2006 Jun; 33(3):324-32. PubMed ID: 16769421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The double-edged sword: Neurotoxicity of chemotherapy.
    Magge RS; DeAngelis LM
    Blood Rev; 2015 Mar; 29(2):93-100. PubMed ID: 25445718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.